A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new research warns. The findings highlight the need ...

This double-blind trial enrolled adults with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. All patients received combination antifungal therapy of ...

Please provide your email address to receive an email when new articles are posted on . A large study conducted in five African countries identified an easier and less toxic treatment for ...

"The results of this phase 3 [AMBITION-cm] trial make it clear that this approach is just as good as the current World Health Organization-recommended first-line treatment in preventing death," first ...

ABOUT 500 cases of human infection due to Cryptococcus neoformans have been described since Busse and Buschke separately presented descriptions of clinical findings in the same patient. In addition ...

Several immune cells help fungi infect the brain and cause meningitis when they should be doing the exact opposite. From the University of Sydney, researchers investigate the immune system’s ...

Meningitis is an inflammation of the protective membranes covering the brain and spinal cord. It has three main causes: bacterial, viral, and fungal, each requiring a different treatment approach.